Elevated promoter methylation events involved 168 genes with reduced tumor expression, and it was notable that promoter hypermethylation of AMT, CCL21 and SPARCL1 were detected in the vast majority of tumors (15). The gene discussed is SPARCL1; the disease is neoplasm.